<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 22:33:04[mciao0828] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<header>
<title>Pharmacoeconomics</title>
<id>6989424</id>
<revision>
<id>208058506</id>
<timestamp>2008-04-25T06:48:26Z</timestamp>
<contributor>
<username>Vina-iwbot</username>
<id>727408</id>
</contributor>
</revision>
<categories>
<category>Health economics</category>
<category>Pharmacology</category>
<category>Public health</category>
</categories>
</header>
<bdy>

<b>Pharmacoeconomics</b> refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is a sub-discipline of <link xlink:type="simple" xlink:href="../753/265753.xml">
Health economics</link>. A pharmacoeconomic study evaluates the cost (expressed in monetary terms) and effects (expressed in terms of monetary value, efficacy or enhanced <link xlink:type="simple" xlink:href="../789/47789.xml">
quality of life</link>) of a pharmaceutical product. We can distinguish several types of pharmacoeconomic evaluation:<link xlink:type="simple" xlink:href="../999/10089999.xml">
cost-minimization analysis</link>, <link xlink:type="simple" xlink:href="../583/374583.xml">
cost-benefit analysis</link>, <link xlink:type="simple" xlink:href="../128/265128.xml">
cost-effectiveness analysis</link> and <link xlink:type="simple" xlink:href="../154/1393154.xml">
cost-utility analysis</link>. Pharmacoeconomic studies serve to guide optimal healthcare resource allocation, in a standardized and scientifically grounded manner.<p>

One important consideration in a pharmacoeconomic evaluation is to decide the <link xlink:type="simple" xlink:href="../964/10669964.xml">
perspective</link> from which the analysis should be conducted (such as institutional or societal).</p>
<p>

A complete compilation of cost-utility analyses in the peer reviewed medical literature is available at the <weblink xlink:type="simple" xlink:href="http://www.tufts-nemc.org/CEARegistry">
The CEA Registry Website</weblink>.</p>

<sec>
<st>
 Academic resources </st>
<p>

<list>
<entry level="1" type="bullet">

 <it>PharmacoEconomics</it>, ISSN 1170-7690, Adis International</entry>
<entry level="1" type="bullet">

 <it>Value in Health</it>, ISSN: 1524-4733 (internet), 1098-3015 (print), <company wordnetid="108058098" confidence="0.8">
<institution wordnetid="108053576" confidence="0.8">
<link xlink:type="simple" xlink:href="../268/4694268.xml">
Blackwell Publishing</link></institution>
</company>
</entry>
</list>
</p>

</sec>
<sec>
<st>
See also</st>
<p>

<list>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../999/10089999.xml">
Cost-minimization analysis</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../128/265128.xml">
Cost-effectiveness analysis</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../583/374583.xml">
Cost-benefit analysis</link></entry>
<entry level="1" type="bullet">

 <link>
Cost-of-illness</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../154/1393154.xml">
Cost-utility analysis</link></entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../577/4144577.xml">
Disability-adjusted life years</link> - DALYs</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../259/6716259.xml">
Global burden of disease</link></entry>
<entry level="1" type="bullet">

<link>
Global comparative cost of pharmaceutical molecule</link></entry>
<entry level="1" type="bullet">

 <link>
Health utility index</link></entry>
<entry level="1" type="bullet">

 <link>
Health-adjusted life years</link> - HALYs</entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../964/10669964.xml">
Perspective (pharmacoeconomic)</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../169/1393169.xml">
Quality-adjusted life years</link> - QALYs</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../789/47789.xml">
Quality of life</link></entry>
</list>
</p>

</sec>
<sec>
<st>
External links</st>

<p>

<list>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.ispor.org">
International Society For Pharmacoeconomics and Outcomes Research</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://ispor.co.googlepages.com">
ISPOR-CO, The Colombian Chapter of The International Society for Pharmacoeconomics and Outcomes Research</weblink></entry>
</list>
</p>

<p>

<list>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.healtheconomics.com/">
HealthEconomics.Com</weblink></entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.healtheconomics.nl">
Health Economics and Pharmacoeconomics Glossary of Terms - maintained by the University of Groningen, the Netherlands</weblink></entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.future-drugs.com/loi/erp">
Expert Review of Pharmacoeconomics and Outcomes Research - Peer-reviewed journal published by Future Science Group</weblink></entry>
</list>
</p>



</sec>
</bdy>
</article>
